Rosenwald A, Ott G, Stilgenbauer S, Kalla J, Bredt M, Katzenberger T, Greiner A, Ott M M, Gawin B, Döhner H, Müller-Hermelink H K
Pathologisches Institut, Universität Würzburg, Würzburg, Germany.
Am J Pathol. 1999 Dec;155(6):1817-21. doi: 10.1016/S0002-9440(10)65499-5.
Extranodal mucosa-associated lymphoid tissue (MALT)-type lymphomas and nodal and splenic marginal zone B cell lymphomas (MZBL) share morphological and immunophenotypic features with marginal zone B cells of reactive lymphoid tissues. Although displaying a similar immunophenotype, recent investigations suggest fundamental genetic differences among these subgroups. To determine the prevalence of the t(11;18) in a larger series of MALT-type lymphomas and to investigate a possible occurrence in other lymphomas, we screened 106 non-Hodgkin's lymphomas (NHL) by interphase cytogenetics using yeast artificial chromosome (YAC) probes flanking the breakpoint at 11q21. A signal constellation indicating a disruption in 11q21 and thus pointing to the presence of the t(11;18) was observed in 9 of 33 (27%) low-grade lymphomas of MALT type. The complete absence of t(11;18)-positive cells in 32 primary and secondary extranodal high-grade lymphomas suggests that low-grade lymphomas of MALT type characterized by the t(11;18) are unlikely to transform into high-grade tumors. The absence of tumor cells carrying the t(11;18) in nodal MZBL challenges the assumption that most, if not all, of these tumors represent the nodal manifestation of a so far undetected low-grade lymphoma of MALT type. The t(11;18) was not detected in a single case of 29 splenic MZBL investigated. This observation strengthens the view that splenic MZBL are biologically different from extranodal MZBL of MALT type.
结外黏膜相关淋巴组织(MALT)型淋巴瘤以及淋巴结和脾脏边缘区B细胞淋巴瘤(MZBL)与反应性淋巴组织的边缘区B细胞具有形态学和免疫表型特征。尽管表现出相似的免疫表型,但最近的研究表明这些亚组之间存在根本的基因差异。为了确定在更大系列的MALT型淋巴瘤中t(11;18)的发生率,并研究其在其他淋巴瘤中的可能发生情况,我们使用位于11q21断点侧翼的酵母人工染色体(YAC)探针,通过间期细胞遗传学对106例非霍奇金淋巴瘤(NHL)进行了筛查。在33例MALT型低级别淋巴瘤中的9例(27%)中观察到一种信号组合,表明11q21发生了断裂,从而提示存在t(11;18)。在32例原发性和继发性结外高级别淋巴瘤中完全没有t(11;18)阳性细胞,这表明以t(11;18)为特征的MALT型低级别淋巴瘤不太可能转化为高级别肿瘤。在淋巴结MZBL中没有携带t(11;18)的肿瘤细胞,这对以下假设提出了挑战,即这些肿瘤中的大多数(如果不是全部)代表了迄今未被发现的MALT型低级别淋巴瘤的淋巴结表现。在研究的29例脾脏MZBL中,没有一例检测到t(11;18)。这一观察结果强化了脾脏MZBL在生物学上与MALT型结外MZBL不同的观点。